SynapCon
SynapCon GmbH develops advanced digital technologies and business models focused on accelerating clinical development of drugs and medical devices. Their fully integrated software suite supports global biotech, medtech, IVD, and pharma trials with audit-proof, secure, and reliable end-to-end solutions. The company combines pre-trial services, clinical trial management, and AI-driven big data analytics to massively increase efficiency, shorten development cycles, and reduce costs, enabling faster access to healthcare worldwide. Developed in the UK, Germany, and Austria, SynapCon is publicly sponsored by German ministries and has over 30 years of experience, 250+ business partners, and operations in 78 studies across 78 countries. Their product disrupts traditional paper-based trials with a modern, affordable, and easy-to-use digital platform, emphasizing sustainability and compliance with international standards such as ISO 14155, ISO 14971, GAMP-5, FDA, EMA, GDPR, and others.
SynapCon
SynapCon GmbH develops advanced digital technologies and business models focused on accelerating clinical development of drugs and medical devices. Their fully integrated software suite supports global biotech, medtech, IVD, and pharma trials with audit-proof, secure, and reliable end-to-end solutions. The company combines pre-trial services, clinical trial management, and AI-driven big data analytics to massively increase efficiency, shorten development cycles, and reduce costs, enabling faster access to healthcare worldwide. Developed in the UK, Germany, and Austria, SynapCon is publicly sponsored by German ministries and has over 30 years of experience, 250+ business partners, and operations in 78 studies across 78 countries. Their product disrupts traditional paper-based trials with a modern, affordable, and easy-to-use digital platform, emphasizing sustainability and compliance with international standards such as ISO 14155, ISO 14971, GAMP-5, FDA, EMA, GDPR, and others.